Dr. Daniel S. Behroozan, M..D.
Dermatology (Dermatology Physician)
2221 Lincoln Blvd, Suite 100
Santa Monica, CA 90405
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 508
Licensed in California since 2001, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
CA license A76756 (first issued 2001; current) -
MOHS-Micrographic Surgery Physician
CA license A76756 (first issued 2001; current) -
Procedural Dermatology Physician
CA license A76756 (first issued 2001; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Daniel Behroozan MD A Medical Corporation (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 508
- Services billed
- 2,837
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 363 | 226 |
| Destruction of precancer skin growth, 2-14 growths | 336 | 68 |
| Biopsy of related skin growth, first growth | 204 | 152 |
| Destruction of skin growth, 1-14 growths | 166 | 131 |
| Destruction of precancer skin growth, 15 or more growths | 141 | 86 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 140 | 109 |
| Destruction of precancer skin growth, 1 growth | 125 | 99 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 103 | 79 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 101 | 66 |
| Biopsy of related skin growth, each additional growth | 85 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 115 payments worth $9,857 in total to this clinician.
| Galderma Laboratories, L.P. | $6,832 |
|---|---|
| AbbVie Inc. | $1,486 |
| Almirall LLC | $279 |
| Amgen Inc. | $256 |
| Incyte Corporation | $231 |
| Leo Pharma Inc. | $170 |
| Journey Medical Corporation | $152 |
| Sun Pharmaceutical Industries Inc. | $87.68 |
| Compensation for services other than consulting (speaking, faculty) | $6,779 |
|---|---|
| Food and Beverage | $3,078 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Galderma Laboratories, L.P. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) AKLIEF · ACNE | $3,600 |
| Galderma Laboratories, L.P. Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) AKLIEF · ACNE | $2,600 |
| AbbVie Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $135 |
| AbbVie Inc. Jan 7, 2025 | Compensation for services other than consulting (speaking, faculty) | $97.75 |
| AbbVie Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $90.97 |
| AbbVie Inc. Aug 7, 2025 | Compensation for services other than consulting (speaking, faculty) | $87.00 |
| AbbVie Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) | $87.00 |
| AbbVie Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $69.00 |
| AbbVie Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $12.75 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.